Efficacy and safety of immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis

Background and purpose: Although immune checkpoint inhibitors (ICIs) have become the first-line treatment for metastatic non-small cell lung cancer (mNSCLC), their efficacy is limited. Meanwhile, recent reports suggest that radiotherapy (RT) can activate the systemic antitumor immune response by inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zijing, Xu, Tiankai, Chang, Pengyu, Fu, Weijia, Wei, Jiaying, Xia, Chengcheng, Wang, Qiang, Li, Man, Pu, Xiaoyu, Huang, Fuxue, Ge, Chao, Gao, Yan, Gong, Shouliang, Liu, Chengjiang, Dong, Lihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902364/
https://www.ncbi.nlm.nih.gov/pubmed/36762107
http://dx.doi.org/10.3389/fphar.2023.1064227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902364/
https://www.ncbi.nlm.nih.gov/pubmed/36762107
http://dx.doi.org/10.3389/fphar.2023.1064227

Ejemplares similares